GlassScriptPhysician profile
Vasudeva Goli
NPI 1114982881
$5,589.67
in general payments reported to CMS, 2019-2025
33 companies · $617 in 2025
The $617 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,160 · 2020: $566 · 2021: $777 · 2022: $733 · 2023: $851 · 2024: $885 · 2025: $617.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,353.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,352.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $827.95 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $826.17 | 2019-2025 | Farxiga, Wainua, Lokelma |
| Janssen Pharmaceuticals, INC | $654.40 | 2019-2022 | |
| Amgen INC. | $437.06 | 2019-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $376.21 | 2019-2025 | Camzyos, Eliquis |
| Pfizer INC. | $278.76 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $270.55 | 2021-2025 | Verquvo |
| Alnylam Pharmaceuticals INC. | $210.76 | 2025 | Amvuttra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $184.10 | 2019-2024 | Jardiance |
| Sanofi-Aventis U.S. LLC | $183.26 | 2019-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $181.78 | 2019-2024 | Lifevest |
| Boston Scientific Corporation | $154.98 | 2023-2024 | Watchman Access System |
| Abiomed | $139.47 | 2019 | |
| Lantheus Medical Imaging, INC. | $122.12 | 2021 | |
| Silk Road Medical, INC. | $92.32 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $82.63 | 2019-2020 | |
| Abbott Laboratories | $67.91 | 2019-2022 | |
| Preventice Services, LLC | $52.78 | 2020 | |
| Medtronic Vascular, INC. | $45.67 | 2020 | |
| Chiesi USA, INC. | $45.55 | 2019 | |
| Bridgebio Pharma, INC. | $41.99 | 2025 | Attruby |
| Lexicon Pharmaceuticals, INC. | $41.84 | 2024 | |
| Amarin Pharma, INC. | $39.24 | 2019 | |
| Medtronic, INC. | $34.96 | 2022 | |
| Angiodynamics, INC. | $29.70 | 2025 | Alphavac |
| Inari Medical, INC. | $27.69 | 2022 | |
| Glaxosmithkline, LLC. | $27.00 | 2025 | Shingrix, Arexvy |
| Scpharmaceuticals INC. | $26.11 | 2023 | |
| Edwards Lifesciences Corporation | $19.17 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Esperion Therapeutics, INC. | $18.88 | 2020 | |
| Irhythm Technologies, INC. | $17.66 | 2023 | Zio Xt Patch |
| Baxter Healthcare | $17.33 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Alexion Pharmaceuticals, INC. | $13.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vasudeva Goli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.